Weight loss injections primarily refer to glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Wegovy), tirzepatide (Zepbound), and liraglutide (Saxenda)
Depre C, Antalik L, Starling A, Koren M, Eisele O, Lenz RA, Mikol DD
The trial, GLORY-1 , not only marks a breakthrough for Chinese drug innovation but also establishes mazdutide as a globally significant contender in obesity treatment
No packages
Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials
Ulloque-BadaraccoJRAl-Kassab-CordovaAAlarcon-BragaEAHernandez-BustamanteEAHuyata-CortezMACabrera-GuzmnJCet al